Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for He… (NCT07222358) | Clinical Trial Compass
WithdrawnNot Applicable
Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery
Stopped: After PI and vendor discussions, the decision was made not to proceed with the contract. The vendor's focus on large commercial efforts limits feasibility to support St. Jude clinical trial work.
0Started 2026-04
Plain-language summary
This feasibility study evaluates a 12-week, multi-component remote assessment program for adult survivors of childhood cancer. The study aims to determine the participation and adherence rates to remote monitoring of cardiometabolic health using wearable devices, surveys, and laboratory testing facilitated by a third-party vendor.
Primary Objective - To establish the feasibility of a multi-component remote assessment program for adult survivors.
* The primary outcome for feasibility will be the participation rate (# eligible survivors approached who enroll) and completion rate (# of eligible survivors who enroll and remain on study through completion).
* An additional outcome for feasibility will be adherence to the multicomponent remote assessment among participants.
Secondary Objective
* To estimate the proportion of participants who complete each individual study component (adherence to each individual component monitoring).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participant is ≥18 years of age
* Participant is enrolled in the St. Jude Life (SJLIFE) cohort
* Participant is able and willing to provide informed consent
* Participant has signed a separate consent for the St. Jude banking protocol (TBANK)
* Participant received anthracycline (≥100 mg/m²), chest or abdominal radiation as part of childhood cancer treatment
* Participant owns a SmartPhone compatible with the vendor platform, Apple HealthKit, and Dexcom (a wearable device that continuously tracks glucose levels)
* Participant verbalizes understanding directions for completing remote study activities with the third-party partner
* Participant is fluent in English
Exclusion Criteria:
* Participant uses a continuous glucose monitor for diabetes management or has diabetes requiring insulin or more than 1 agent for treatment at baseline
* Participant is currently enrolled on an intervention or active longitudinal monitoring ancillary study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Participation rate
Timeframe: Assessed at contact for enrollment of each participant (baseline/screening).
2
On-boarding rate
Timeframe: Baseline at study entry through week 12
3
Completion rate
Timeframe: Baseline at study entry through week 12
4
Adherence to the remote monitoring intervention
Timeframe: Baseline at study entry through week 12